FAKTOR-OPTIONSSCHEIN - HALEON Share Price

Certificat

DE000MG1K2V5

Real-time Bid/Ask 08:06:24 06/06/2024 pm IST
9.64 EUR / 9.68 EUR -5.20% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month-2.67%
1 month+3.66%
Date Price Change
06/24/06 9.6 -5.79%
05/24/05 10.19 +0.30%
04/24/04 10.16 -2.40%
03/24/03 10.41 -0.57%
31/24/31 10.47 +0.19%

Delayed Quote Börse Stuttgart

Last update June 06, 2024 at 04:35 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG1K2V
ISINDE000MG1K2V5
Date issued 03/04/2024
Strike 409.8 p
Maturity Unlimited
Parity 0.1 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.59
Lowest since issue 8.99
Spread 0.04
Spread %0.41%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.278 GBP
Average target price
3.646 GBP
Spread / Average Target
+11.24%
Consensus